表紙:ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測:2020年~2027年
市場調査レポート
商品コード
1027061

ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測:2020年~2027年

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日: | 発行: Value Market Research | ページ情報: 英文 210 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
ヒトマイクロバイオームの世界市場 - 業界分析、市場規模、シェア、成長率、動向、予測:2020年~2027年
出版日: 2021年08月01日
発行: Value Market Research
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトマイクロバイオーム市場は、過去数年間で著しい成長を遂げ、2021年~2027年の予測期間中に大幅な成長が予想されています。

当レポートでは、世界のヒトマイクロバイオーム市場について調査分析し、市場促進要因・抑制要因・課題・機会のほか、収益に関する市場の発展について、体系的な情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 ヒトマイクロバイオーム:業界分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在的バイヤーのリスト
  • マーケティングチャネル

第5章 COVID-19アウトブレイクの影響分析

  • COVID-19アウトブレイクの影響分析
  • COVID-19の影響分析:生産・輸入・輸出・需要別
  • 市場:COVID-19以前 vs. COVID-19以後
  • COVID-19エピデミックの推定される影響
  • COVID-19:マイクロ/マクロ要因分析

第6章 世界のヒトマイクロバイオーム市場分析:製品別

  • 概要:製品別
  • 実績データと予測データ
  • 分析:製品別
  • プロバイオティクス
  • プレバイオティクス
  • 診断検査
  • 医薬品
  • その他

第7章 世界のヒトマイクロバイオーム市場分析:疾患別

  • 概要:疾患別
  • 実績データと予測データ
  • 分析:疾患別
  • 感染症
  • 内分泌・代謝障害
  • 胃腸疾患
  • がん
  • その他

第8章 世界のヒトマイクロバイオーム市場分析:用途別

  • 概要:用途別
  • 実績データと予測データ
  • 分析:用途別
  • 治療
  • 診断

第9章 世界のヒトマイクロバイオーム市場分析:技術別

  • 概要:技術別
  • 実績データと予測データ
  • 分析:技術別
  • ゲノミクス
  • プロテオミクス
  • メタボロミクス

第10章 世界のヒトマイクロバイオーム市場分析:地域別

  • 地域別の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 ヒトマイクロバイオーム企業の競合情勢

  • ヒトマイクロバイオーム市場競合
  • パートナーシップ/コラボレーション/契約
  • M&A
  • 新製品発売
  • その他の発展

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Embion Technologies SA
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • IGEN BIOLAB GROUP
  • 4D Pharma Plc.
  • Ferring Pharmaceuticals
  • Gnubiotics Sciences
  • YSOPIA Bioscience
  • ViThera Pharmaceuticals Inc.
  • Gnubiotics Sciences
  • Osel Inc.
  • SECOND GENOME THERAPEUTICS
  • Immuron Ltd.
  • OxThera AB
  • AOBiome
  • Vedanta Biosciences Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Probiotics Market by Geography (USD MN)
  • Prebiotics Market by Geography (USD MN)
  • Diagnostic Tests Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Other Products Market by Geography (USD MN)
  • Analysis Market by Disease (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Endocrine and Metabolic Disorders Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Cancer Market by Geography (USD MN)
  • Other Diseases Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Therapeutics Market by Geography (USD MN)
  • Diagnostics Market by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Genomics Market by Geography (USD MN)
  • Proteomics Market by Geography (USD MN)
  • Metabolomics Market by Geography (USD MN)
  • Global Human Microbiome Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Human Microbiome Report
  • Market Research Process
  • Market Research Methodology
  • Global Human Microbiome Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Disease
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Probiotics Market by Geography (USD MN)
  • Prebiotics Market by Geography (USD MN)
  • Diagnostic Tests Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Other Products Market by Geography (USD MN)
  • Global Market Analysis by Disease (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Endocrine and Metabolic Disorders Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Cancer Market by Geography (USD MN)
  • Other Diseases Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Therapeutics Market by Geography (USD MN)
  • Diagnostics Market by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Genomics Market by Geography (USD MN)
  • Proteomics Market by Geography (USD MN)
  • Metabolomics Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215790

Value Market Research's latest report on the Global Human Microbiome Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global human microbiome market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global human microbiome market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global human microbiome market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global human microbiome market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global human microbiome market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global human microbiome market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global human microbiome market.

The market analysis involves a section exclusively to list the major players of the global human microbiome market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Human Microbiome Market Report Segments the market as below:

By Product

  • Probiotics
  • Prebiotics
  • Diagnostic Tests
  • Drugs
  • Other Products

By Disease

  • Infectious Diseases
  • Endocrine and Metabolic Disorders
  • Gastrointestinal Diseases
  • Cancer
  • Other Diseases (Cardiovascular Diseases, Neurological Disorders, Dermatology Diseases, Immune-Modulated Disorders, and Hematological Disorders.)

By Application

  • Therapeutics
  • Diagnostics

By Technology Type

  • Genomics
  • Sequencing
    • 16s rRNA sequencing method
    • Whole-genome sequencing method
    • Other Sequencing methods (shotgun metagenomic sequencing, transcriptomics, and targeted sequencing.)
  • Other Genomic Technologies (Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and DNA Microarrays)
    • Proteomics
    • Metabolomics

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HUMAN MICROBIOME - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product
    • 3.7.2 By Disease
    • 3.7.3 By Application
    • 3.7.4 By Technology
    • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Probiotics Market by Regions
  • 6.5 Prebiotics Market by Regions
  • 6.6 Diagnostic Tests Market by Regions
  • 6.7 Drugs Market by Regions
  • 6.8 Other Products Market by Regions

7 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY DISEASE

  • 7.1 Overview by Disease
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Disease
  • 7.4 Infectious Diseases Market by Regions
  • 7.5 Endocrine and Metabolic Disorders Market by Regions
  • 7.6 Gastrointestinal Diseases Market by Regions
  • 7.7 Cancer Market by Regions
  • 7.8 Other Diseases Market by Regions

8 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Therapeutics Market by Regions
  • 8.5 Diagnostics Market by Regions

9 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY TECHNOLOGY

  • 9.1 Overview by Technology
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Technology
  • 9.4 Genomics Market by Regions
  • 9.5 Proteomics Market by Regions
  • 9.6 Metabolomics Market by Regions

10 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America
    • 10.3.1. Overview, Historic and Forecast Data
    • 10.3.2. North America By Segment
    • 10.3.3. North America By Country
    • 10.3.4. United State
    • 10.3.5. Canada
    • 10.3.6. Mexico
  • 10.4. Europe
    • 10.4.1. Overview, Historic and Forecast Data
    • 10.4.2. Europe by Segment
    • 10.4.3. Europe by Country
    • 10.4.4. United Kingdom
    • 10.4.5. France
    • 10.4.6. Germany
    • 10.4.7. Italy
    • 10.4.8. Russia
    • 10.4.9. Rest Of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Overview, Historic and Forecast Data
    • 10.5.2. Asia Pacific by Segment
    • 10.5.3. Asia Pacific by Country
    • 10.5.4. China
    • 10.5.5. India
    • 10.5.6. Japan
    • 10.5.7. South Korea
    • 10.5.8. Australia
    • 10.5.9. Rest Of Asia Pacific
  • 10.6. Latin America
    • 10.6.1. Overview, Historic and Forecast Data
    • 10.6.2. Latin America by Segment
    • 10.6.3. Latin America by Country
    • 10.6.4. Brazil
    • 10.6.5. Argentina
    • 10.6.6. Peru
    • 10.6.7. Chile
    • 10.6.8. Rest of Latin America
  • 10.7. Middle East & Africa
    • 10.7.1. Overview, Historic and Forecast Data
    • 10.7.2. Middle East & Africa by Segment
    • 10.7.3. Middle East & Africa by Country
    • 10.7.4. Saudi Arabia
    • 10.7.5. UAE
    • 10.7.6. Israel
    • 10.7.7. South Africa
    • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE HUMAN MICROBIOME COMPANIES

  • 11.1. Human Microbiome Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF HUMAN MICROBIOME INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Embion Technologies S.A
    • 12.3.1. Company Overview
    • 12.3.2. Financials
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. ENTEROME SA
    • 12.4.1. Company Overview
    • 12.4.2. Financials
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Evelo Biosciences Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financials
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. IGEN BIOLAB GROUP
    • 12.6.1. Company Overview
    • 12.6.2. Financials
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. 4D Pharma Plc.
    • 12.7.1. Company Overview
    • 12.7.2. Financials
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Ferring Pharmaceuticals
    • 12.8.1. Company Overview
    • 12.8.2. Financials
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Gnubiotics Sciences
    • 12.9.1. Company Overview
    • 12.9.2. Financials
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. YSOPIA Bioscience
    • 12.10.1. Company Overview
    • 12.10.2. Financials
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. ViThera Pharmaceuticals Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financials
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Gnubiotics Sciences
    • 12.12.1. Company Overview
    • 12.12.2. Financials
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Osel Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Financials
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. SECOND GENOME THERAPEUTICS
    • 12.14.1. Company Overview
    • 12.14.2. Financials
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Immuron Ltd.
    • 12.15.1. Company Overview
    • 12.15.2. Financials
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. OxThera AB
    • 12.16.1. Company Overview
    • 12.16.2. Financials
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. AOBiome
    • 12.17.1. Company Overview
    • 12.17.2. Financials
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Vedanta Biosciences Inc.
    • 12.18.1. Company Overview
    • 12.18.2. Financials
    • 12.18.3. Products
    • 12.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies